Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 10/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 4/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775050 | 0.91 | CA1 (0.42) | CA12CA14CA1CA2CA7 | |
| SCHEMBL16592307 | 0.86 | CA12 (0.40) | CA12CA14CA1CA2CA7 | |
| SCHEMBL18082649 | 0.86 | CA12 (0.40) | CA12CA14CA1CA2CA7 | |
| SCHEMBL16760 | 0.84 | CA12 (0.41) | CA12CA14CA1CA2CA7 | |
| SCHEMBL12903896 | 0.83 | MMP1 (0.37) | CA12CA14CA1CA2GAA | |
| SCHEMBL17772585 | 0.81 | CA1 (0.41) | CA12CA14CA1CA2CA7 | |
| SCHEMBL7674937 | 0.79 | CYP2C9 (0.41) | CA12CA14CA1CA2CA7 | |
| SCHEMBL12903913 | 0.78 | MMP1 (0.38) | CA12CA1CA2CYP2D6CYP2C9 | |
| SCHEMBL3105952 | 0.77 | CA1 (0.40) | CA12CA14CA1CA2CA7 | |
| SCHEMBL5966252 | 0.76 | CTSK (0.43) | CA1CA2CA7CTSKCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9714224-B2 | Heterocyclic compounds and methods of their use | NOVARTIS AG (CH) | 2017-07-25 | — | — | US | disclosed |
| US-20160145213-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2016-05-26 | — | — | US | disclosed |
| US-8329935-B2 | Process for producing phosphorus-containing dehydroamino acid | MEJI SEIKA KAISHA LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-8138168-B1 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20110009662-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | MEIJI SEIKA KAISHA LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145213-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE | AGTR2, AGTR1, AGT | CA12 3420/4885CA14 4356/4885CA1 3066/4885 |
| US-20110009662-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | AMPD2, AMPD1, AMPD3 | CA12 2453/4885CA14 2505/4885CA1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.